← Open Payments lookup

MARY WARD: Open Payments

NPI 1821278813 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$443 in 22 payments from 12 companies in 2025. Trend: 2023 $226 · 2024 $298 · 2025 $443

Food & beverage: $443
CompanyPaymentsAmount
Corcept Therapeutics4$102
Abbott Laboratories3$58
Bayer Healthcare Pharmaceuticals Inc.3$49
Tandem Diabetes Care, Inc.2$40
Averitas Pharma Inc.1$37
Lilly USA, LLC2$33
AstraZeneca Pharmaceuticals LP2$30
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Sequel Med Tech, LLC1$19
Madrigal Pharmaceuticals1$18

Products named: Korlym, FREESTYLE LIBRE 3, Kerendia, t:slim X2 Insulin Pump with Control-IQ, QUTENZA, MOUNJARO, FARXIGA, JARDIANCE.

Industry payments across MS — which companies pay providers there.